These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 27647853)
1. Lats1/2 Regulate Yap/Taz to Control Nephron Progenitor Epithelialization and Inhibit Myofibroblast Formation. McNeill H; Reginensi A J Am Soc Nephrol; 2017 Mar; 28(3):852-861. PubMed ID: 27647853 [TBL] [Abstract][Full Text] [Related]
2. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557 [TBL] [Abstract][Full Text] [Related]
3. LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development. Lee DH; Park JO; Kim TS; Kim SK; Kim TH; Kim MC; Park GS; Kim JH; Kuninaka S; Olson EN; Saya H; Kim SY; Lee H; Lim DS Nat Commun; 2016 Jun; 7():11961. PubMed ID: 27358050 [TBL] [Abstract][Full Text] [Related]
4. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas. Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373 [TBL] [Abstract][Full Text] [Related]
5. Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells. Abou Nader N; Charrier L; Meisnsohn MC; Banville L; Deffrennes B; St-Jean G; Boerboom D; Zamberlam G; Brind'Amour J; Pépin D; Boyer A FASEB J; 2024 May; 38(9):e23633. PubMed ID: 38690712 [TBL] [Abstract][Full Text] [Related]
6. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate. Abou Nader N; Ménard A; Levasseur A; St-Jean G; Boerboom D; Zamberlam G; Boyer A Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362374 [TBL] [Abstract][Full Text] [Related]
7. Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation. Wu Y; Qin K; Xu Y; Rajhans S; Vo T; Lopez KM; Liu J; Nipper MH; Deng J; Yin X; Ramjit LR; Ye Z; Luan Y; Arda HE; Wang P Elife; 2024 Jul; 13():. PubMed ID: 39051998 [TBL] [Abstract][Full Text] [Related]
8. Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. Wu LMN; Deng Y; Wang J; Zhao C; Wang J; Rao R; Xu L; Zhou W; Choi K; Rizvi TA; Remke M; Rubin JB; Johnson RL; Carroll TJ; Stemmer-Rachamimov AO; Wu J; Zheng Y; Xin M; Ratner N; Lu QR Cancer Cell; 2018 Feb; 33(2):292-308.e7. PubMed ID: 29438698 [TBL] [Abstract][Full Text] [Related]
9. Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ. Liu Z; Wei Y; Zhang L; Yee PP; Johnson M; Zhang X; Gulley M; Atkinson JM; Trebak M; Wang HG; Li W Oncogene; 2019 Jan; 38(1):120-139. PubMed ID: 30082911 [TBL] [Abstract][Full Text] [Related]
10. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2. Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470 [TBL] [Abstract][Full Text] [Related]
11. YAP and TAZ are distinct effectors of corneal myofibroblast transformation. Muppala S; Raghunathan VK; Jalilian I; Thomasy S; Murphy CJ Exp Eye Res; 2019 Mar; 180():102-109. PubMed ID: 30578787 [TBL] [Abstract][Full Text] [Related]
12. Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. Bagherie-Lachidan M; Reginensi A; Pan Q; Zaveri HP; Scott DA; Blencowe BJ; Helmbacher F; McNeill H Development; 2015 Aug; 142(15):2564-73. PubMed ID: 26116661 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis. Mohad V; Lungova V; Verheyden J; Thibeault SL Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576 [TBL] [Abstract][Full Text] [Related]
14. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice. Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369 [TBL] [Abstract][Full Text] [Related]
15. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner. Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386 [TBL] [Abstract][Full Text] [Related]
16. Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774 [TBL] [Abstract][Full Text] [Related]
17. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis. Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529 [TBL] [Abstract][Full Text] [Related]
18. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Imajo M; Ebisuya M; Nishida E Nat Cell Biol; 2015 Jan; 17(1):7-19. PubMed ID: 25531778 [TBL] [Abstract][Full Text] [Related]
19. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
20. The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number. Lavado A; Park JY; Paré J; Finkelstein D; Pan H; Xu B; Fan Y; Kumar RP; Neale G; Kwak YD; McKinnon PJ; Johnson RL; Cao X Dev Cell; 2018 Dec; 47(5):576-591.e8. PubMed ID: 30523785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]